Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» daratumumab
daratumumab
These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
Motley Fool
Tue, 09/3/13 - 09:33 am
FDA
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
Novartis
LDK378
serelaxin
daratumumab
Genmab
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
Johnson & Johnson's Potential Blockbuster For Multiple Myeloma And Its Competitors
Seeking Alpha
Tue, 06/4/13 - 09:36 am
JNJ
Multiple Myeloma
daratumumab
Genmab
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Bloomberg
Thu, 05/2/13 - 10:31 am
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
Genmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover
Bloomberg
Wed, 03/20/13 - 12:09 pm
Genmab
JNJ
daratumumab
Multiple Myeloma
Genmab Rises as Danske Sees FDA Breakthrough: Copenhagen Mover
Bloomberg
Fri, 02/15/13 - 10:58 am
Genmab
FDA
daratumumab
Genmab, Johnson & Johnson agree $1.1 billion cancer deal
Reuters
Thu, 08/30/12 - 09:38 am
Genman
JNJ
daratumumab
cancer
Pages
« first
‹ previous
1
2